PMID- 34953054 OWN - NLM STAT- MEDLINE DCOM- 20220301 LR - 20220301 IS - 2050-6414 (Electronic) IS - 2050-6406 (Print) IS - 2050-6406 (Linking) VI - 10 IP - 1 DP - 2022 Feb TI - Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment. PG - 73-79 LID - 10.1002/ueg2.12186 [doi] AB - BACKGROUND: Although endoscopic retrograde cholangiopancreatography (ERCP) is a pivotal procedure for the diagnosis and treatment of a variety of pancreatobiliary diseases, it has been known that the risk of procedure-related adverse events (AEs) is significant. OBJECTIVE: We conducted this nationwide cohort study since there have been few reports on the real-world data regarding ERCP-related AEs. METHODS: Patients who underwent ERCP were identified between 2012 and 2015 using Health Insurance Review and Assessment database generated by the Korea government. Incidence, annual trends, demographics, characteristics according to the types of procedures, and the risk factors of AEs were assessed. RESULTS: A total of 114,757 patients with male gender of 54.2% and the mean age of 65.0 +/- 15.2 years were included. The most common indication was choledocholithiasis (49.4%) and the second malignant biliary obstruction (22.8%). Biliary drainage (33.9%) was the most commonly performed procedure, followed by endoscopic sphincterotomy (27.4%), and stone removal (22.0%). The overall incidence of ERCP-related AEs was 4.7% consisting of post-ERCP pancreatitis (PEP; 4.6%), perforation (0.06%), and hemorrhage (0.02%), which gradually increased from 2012 to 2015. According to the type of procedures, ERCP-related AEs developed the most commonly after pancreatic stent insertion (11.4%), followed by diagnostic ERCP (5.9%) and endoscopic sphincterotomy (5.7%). Younger age and diagnostic ERCP turned out to be independent risk factors of PEP. CONCLUSIONS: ERCP-related AEs developed the most commonly after pancreatic stent insertion, diagnostic ERCP and endoscopic sphincterotomy. Special caution should be used for young patients receiving diagnostic ERCP due to increased risk of PEP. CI - (c) 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology. FAU - Jang, Dong Kee AU - Jang DK AD - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea. FAU - Kim, Jungmee AU - Kim J AD - Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. FAU - Paik, Chang Nyol AU - Paik CN AUID- ORCID: 0000-0002-3470-6904 AD - Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. FAU - Kim, Jung-Wook AU - Kim JW AD - Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea. FAU - Lee, Tae Hee AU - Lee TH AD - Institute for Digestive Research, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea. FAU - Jang, Jae-Young AU - Jang JY AD - Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea. FAU - Yoon, Seung Bae AU - Yoon SB AUID- ORCID: 0000-0002-6119-7236 AD - Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. FAU - Lee, Jun Kyu AU - Lee JK AUID- ORCID: 0000-0002-2694-3598 AD - Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211224 PL - England TA - United European Gastroenterol J JT - United European gastroenterology journal JID - 101606807 SB - IM CIN - United European Gastroenterol J. 2022 Feb;10(1):10-11. PMID: 35134279 MH - Age Factors MH - Aged MH - Cholangiopancreatography, Endoscopic Retrograde/*adverse effects/statistics & numerical data MH - Choledocholithiasis/diagnostic imaging/therapy MH - Cholestasis/diagnostic imaging/therapy MH - Cohort Studies MH - Databases, Factual MH - Drainage/statistics & numerical data MH - Female MH - Hemorrhage/*etiology MH - Humans MH - International Classification of Diseases MH - Male MH - Pancreatitis/epidemiology/*etiology MH - Republic of Korea MH - Risk Factors MH - Sphincterotomy, Endoscopic/adverse effects/statistics & numerical data MH - Stents/adverse effects PMC - PMC8830275 OTO - NOTNLM OT - Korea OT - complication OT - endoscopic retrograde cholangiopancreatography OT - hemorrhage OT - pancreatitis OT - perforation COIS- The authors have no conflicts of interest to declare. EDAT- 2021/12/26 06:00 MHDA- 2022/03/03 06:00 PMCR- 2021/12/24 CRDT- 2021/12/25 05:42 PHST- 2021/09/06 00:00 [received] PHST- 2021/11/21 00:00 [accepted] PHST- 2021/12/26 06:00 [pubmed] PHST- 2022/03/03 06:00 [medline] PHST- 2021/12/25 05:42 [entrez] PHST- 2021/12/24 00:00 [pmc-release] AID - UEG212186 [pii] AID - 10.1002/ueg2.12186 [doi] PST - ppublish SO - United European Gastroenterol J. 2022 Feb;10(1):73-79. doi: 10.1002/ueg2.12186. Epub 2021 Dec 24.